Sameh Khair

Syreon Middle East is at the forefront of health economics in the MENA region, contributing significantly to Health Technology Assessment (HTA) in Egypt. Through dedicated efforts, we have played a major role in HTA implementation, driving forward the country's healthcare system. Our commitment is reflected in the remarkable progress Egypt has achieved in HTA's milestones, paving the way for sustainable healthcare development: 1️) Capacity Building: We've spearheaded specialized training programs, including advanced individual patient simulation, budget impact analysis, and comprehensive one-year technical training. These initiatives elevate local expertise, ensuring HTA processes are rooted in a deep understanding of our healthcare landscape. 2️) Research & Publication: Our research endeavors have flourished, resulting in two influential papers on Multi-Criteria Decision Analysis (MCDA) for out-of-patent pharmaceuticals and medical devices, expanding the scope of HTA's impact. 3️) Decision-Making Criteria: We've launched two pivotal projects on cost-effectiveness analysis—one establishing the Cost-Effectiveness Threshold (CET) based on multipliers, and another tailored for orphan drugs, providing critical modifiers for decision-making in HTA. This journey represents only a fragment of our ongoing commitment to enhancing healthcare through robust economic evaluation and evidence-based decision-making. #SyreonMiddleEast #HTA #HealthcareEconomics #EgyptHealthcare #Innovation #PolicyMaking

١٠

🌟 Raising a Generation that Values the Human-Animal Bond 🌟In today’s fast-paced world, fostering empathy and compassion in our children is more important than ever. One powerful way to achieve this is by nurturing the human-animal bond. 🐾 Why is this important? Emotional Development: Interacting with animals helps children develop empathy, responsibility, and emotional intelligence. Mental Health: Pets provide companionship and reduce stress, anxiety, and loneliness. Social Skills: Caring for animals teaches children about teamwork, patience, and communication. Innovative Approach: Simulating a Pet Clinic Imagine a classroom where children can role-play as veterinarians, pet owners, and animal caregivers. This simulation not only makes learning fun but also instills a deep sense of responsibility and care for animals. 🏥 Benefits of a Pet Clinic Simulation: Hands-On Learning: Children learn about animal health, nutrition, and behavior through interactive activities. Problem-Solving Skills: They tackle real-life scenarios, enhancing their critical thinking and decision-making abilities. Career Inspiration: Exposure to veterinary science can inspire future careers in animal care and welfare. Let’s work together to raise a generation that cherishes and respects the bond between humans and animals. By integrating pet clinic simulations into education, we can create compassionate, responsible, and empathetic future leaders. 🌍❤️ #zoetis #HumanAnimalBond #ChildDevelopment #PetClinicSimulation #Empathy #EducationInnovation

٤٨

٤ تعليق

I was prevailed to receive an invitation to join a podcast tomorrow (Friday 6 Dec, 2024) as an expert with Dr. Abdelrahman Baz in Repsology LIVE podcast🎙. we will talk about the impact of AI and digital revolution on the future of pharmaceutical promotion. Tune in tomorrow at 8:00 PM GMT (10:00 PM Cairo time)! 🎙️👨‍⚕️💊 #AI #Podcast #Pharmaceuticals #Technology #Future #DigitalRevolution #Medicine

٦١

٦ تعليق

Where the world of healthcare meets Don't miss the 50th edition of Arab Health next year! As the healthcare industry's most influential event, Arab Health plays a crucial role in connecting regional and international leaders, thought leaders, and healthcare professionals through trade and innovation. #ArabHealth #ArabHealth2025

٤٣

١ تعليق واحد

Introducing the Arab Pharma Expert's Association: A New Era in Pharmaceutical Excellence Distinguished colleagues and fellow pharmaceutical professionals, I am honored to announce the upcoming launch of the Arab Pharma Expert's Association, set for next October at the International Exhibition for Pharmaceuticals and Medical Equipment (IEPM) in Dubai. This event will mark a significant milestone in advancing pharmaceutical excellence in the Arab world. As a founder, I'm proud to introduce an organization born from a vision of unity, knowledge-sharing, and innovation in all fields of pharma and not only of specific field like other existing associations. We aim to foster collaboration, enhance professional standards, and drive technological advancements across the Arab pharmaceutical landscape. Our association will be built on four key pillars: Knowledge Exchange Regulatory Harmonization Innovation Promotion Professional Development To underscore our commitment, we'll inaugurate an advanced course in Good Manufacturing Practices (GMP). I invite all pharmaceutical scientists, regulatory experts, industry leaders, and policymakers to join us in shaping the future of Arab pharmaceuticals. Together, we can build a robust, innovative, and globally competitive sector that addresses our region's healthcare needs and contributes to global advancements. The launch next October isn't just the beginning of an organization; it's the start of a movement toward pharmaceutical excellence. Join us on this transformative journey as we elevate the Arab pharmaceutical industry to new heights. We look forward to welcoming you as members and partners and realizing our shared vision for the future of Arab pharmaceuticals. #ArabPharmaExperts #PharmaceuticalExcellence #IEPM2024

١٢

M&A in the MENA Pharma Market: A Complex Landscape Despite high growth potential, the MENA pharma market remains a challenging environment for M&A. Inflated valuations, deep market nuances, and government protectionism continue to hinder successful deals. While the region has seen notable acquisitions like Sanofi's purchase of UAE-based Global Pharma and Valeant's acquisition of UAE-based Medpharma in 2014, these examples also highlight the complexities involved. It's clear that a deep understanding of local dynamics and a long-term perspective are crucial for success. While PE firms remain active, the path to a profitable M&A deal is still fraught with challenges. What are your thoughts on the MENA pharma M&A landscape? Share your insights and experiences below. #MENApharma #M&A #pharmaindustry #pharmabusiness #challenges #investment #PE

٣

📣 Abu Dhabi: The Emerging Global Pharma & Life Sciences Hub #AbuDhabi is making significant strides to position itself as a major global hub for pharmaceutical and life sciences distribution. This effort has recently gained momentum through a new and strategic partnership between the Department of Health (DoH) in Abu Dhabi, the Abu Dhabi Investment Office (ADIO), Etihad Airways, and AD Ports Group. Announced during the 2024 BIO International Convention, this collaboration seeks to harness Abu Dhabi's strategic location and logistics infrastructure, aiming to boost the healthcare ecosystem by providing advanced healthcare products throughout the MENA region. This initiative aligns with the Abu Dhabi Economic Vision 2030 and is set to attract international pharmaceutical, biotech, and med-tech companies to establish their presence in Abu Dhabi. It also aims to support local manufacturing, enhance healthcare delivery, and create valuable job opportunities in healthcare and logistics. By positioning itself as a key player in global supply chains, Abu Dhabi hopes to drive #sustainablegrowth and establish itself as a leading healthcare destination worldwide. Stay tuned with Anvest Health S.p.A. Società Benefit

٢٢

🌟 Proud Moment for Localized Healthcare in Saudi Arabia! 🌟 I’m excited to share a significant step forward in advancing healthcare in the Kingdom. Sudair Pharmaceutical Company, in collaboration with Sanofi & National Unified Procurement Company "NUPCO" is making strides towards localizing #Insulin production in Saudi Arabia. This initiative isn’t just about meeting the growing demand for insulin in the region but about creating a robust, sustainable supply chain that caters to our unique healthcare landscape. By fostering local production, we aim to: • Ensure reliable access to life-saving insulin for patients across the Kingdom. • Reduce dependency on international supply chains. • Support national goals outlined in Saudi Vision 2030 to enhance self-sufficiency and localize essential industries. This collaboration is a testament to our shared commitment to empowering healthcare, uplifting our economy, and, most importantly, serving the people of Saudi Arabia. Stay tuned as we continue to make healthcare history together! 💪🌍 #Insulin #SaudiVision2030 #SudairPharma #Sanofi

٣١٨

١٠ تعليق

Revolutionizing Patient Care in Saudi Arabia: Infusion Centers Transform Lives Did you know that over 80% of infusion therapy in Saudi Arabia currently happens in crowded metropolitan hubs, requiring many patients to travel 5+ hours for life-saving treatments? This travel burden not only affects patients’ quality of life but also adds significant costs to the healthcare system. IV ONE Health is the region’s first outpatient infusion clinic and a major step towards transforming healthcare delivery in alignment with Vision 2030 and the Health Sector Transformation Program (HSTP). At IVONE, we are bridging critical gaps in care by offering innovative, accessible, and patient-centered infusion therapy solutions. The numbers speak for themselves: • 35% cost savings per patient compared to traditional inpatient care. • Up to 2.7 million infusion treatments needed by 2034, driven by rising prevalence of chronic and autoimmune diseases. • 44 new infusion centers required to meet this growing demand—and IVONE is leading the way. At IV ONE Health we’re setting a new standard in healthcare by decentralizing care, optimizing patient pathways, and leveraging cutting-edge infusion therapies. Patients now have access to advanced treatments in a welcoming environment, closer to home, and at significantly reduced costs. Together, we’re reshaping the patient journey, improving quality of life, and contributing to Saudi Arabia’s vision for a healthier, more sustainable future. Let’s collaborate to bring innovative care to every corner of the region! #IVONE #Vision2030 #HealthcareInnovation #InfusionCenters #PatientCare #Uplifthealthcare #Transforminglifes #SAUDI #KSA

٥

Last week I moderated a panel discussion on Atopic Dermatitis as part of the launch of the second edition of "أخرج للدنيا" or ‘Get out to the world’ awareness campaign. Joined by leading experts like Dr. Hayam Nazif, Vice President of the National Council for Childhood and Motherhood, Dr. Assem Farag, Professor of Dermatology and President of the Egyptian Society of Dermatology and Sharm Derma, and Dr. Amin Sharobim, MD of Dermatology at the National Research Center, we explored the medical and psychological impacts of this chronic skin condition on patients and their families. Atopic Dermatitis, also known as eczema, can have a significant effect on quality of life, causing uncomfortable symptoms like intense itching and dry, irritated skin. Yet many people still lack understanding about this disease. Through " أخرج للدنيا" campaign, we aim to increase public awareness about Atopic Dermatitis, emphasize on the importance of early diagnosis and proper treatment, provide support and resources for patients and help them live normally. By coming together as a healthcare community and by partnering with governmental institutions, we can improve outcomes and reduce the burden for Atopic Dermatitis patients. #PfizerEgypt #AtopicDermatitis #Eczema #Awareness #أخرج_للدنيا https://lnkd.in/did-hmz7

١٤٤

٤ تعليق

Did you know the pharmaceutical market in #SaudiArabia is growing rapidly, and is expected to reach $11.5 billion by 2032. Factors driving growth include: Government investment in healthcare infrastructure  Rising healthcare expenditure  Collaborations between local and international pharmaceutical companies  Medical tourism  I am delighted to be attending CPHI Middle East 8th-10th December. #Connect with me to hear how Sterling Bell Leadership advisory is on the ground in #Riydah, providing solutions including #leadershipprogrammes, #assessments in addition to #executiverecruitment in the #pharmaceutical and #heathcare sectors.  

١٣

Are you need to know how pharmaceutical products moved to patients in Saudi Arabia? The value chain for #pharmaceutical products in #Saudi_Arabia involves several key stages: 1) #Research_and_Development (#R&D): in last decade Saudi Arabia shows an increasing focus on establishing a local R&D infrastructure within the country. 2) #Regulatory Approval: The Saudi Food and Drug Authority (#SFDA) is responsible for ensuring that all pharmaceuticals meet the necessary standards for safety, efficacy, and quality before they are approved for market entry. 3) #Manufacturing: There’s a strategic push towards local manufacturing of both generic and branded drugs to support economic diversification and reduce import dependency. 4) #Distribution: Pharmaceuticals are distributed through hospital pharmacies, and retail pharmacies, ensuring nationwide availability. 5) #Sales_and_Marketing: Companies engage in activities to promote their products to healthcare providers and consumers, including doctor detailing and media advertising which are controlled by SFDA Guidelines and Supervision. 6) #Retail: Pharmacies serve as the final point of sale (in private sector), with ongoing efforts to optimize the supply chain for better drug availability. 7) #Governmental Facilities and Services: #Ministry_of_Health (MoH): The MoH oversees healthcare and health policy in Saudi Arabia. It formulates strategies for public health, manages health infrastructure, and provides integrated healthcare services across all regions. Healthcare in government medical facilities is provided free of charge to citizens based on a new health strategy. #Primary_Care_Centers: These centers offer essential healthcare services to citizens and residents. #Medical_Cities and #Specialized_Hospitals: These facilities provide specialized care, including university and military hospitals. #Hajj and #Umrah Periods: During these religious pilgrimages, healthcare services are extended to millions of visitors. 8)The National Unified Procurement Company (#NUPCO) plays a crucial role in the healthcare value chain in Saudi Arabia. Established in 2009 and fully owned by the #Public_Investment_Fund #PIF, NUPCO is the leading entity in procurement, logistics, and supply chain management for pharmaceuticals, medical devices, and supplies for governmental hospitals in the Kingdom. The pharmaceutical market in Saudi Arabia is expanding due to improvements in healthcare, strategic partnerships, and the introduction of new medications, along with government initiatives to boost local manufacturing capabilities. I tried to make the story as simple as possible. Did I miss anything, or is there anything that needs to be amended to better reflect the real situation?

٢٧

𝙏𝙝𝙚 𝙀𝙫𝙤𝙡𝙫𝙞𝙣𝙜 𝙇𝙖𝙣𝙙𝙨𝙘𝙖𝙥𝙚 𝙤𝙛 𝙋𝙝𝙖𝙧𝙢𝙖 𝙂𝙚𝙣𝙚𝙧𝙞𝙘𝙨 𝙞𝙣 𝙩𝙝𝙚 𝙂𝘾𝘾 𝙧𝙚𝙜𝙞𝙤𝙣 The GCC generic pharma market has undergone a dramatic transformation over the past decade. What once was a lucrative business of launching branded generics at slightly lower prices and gain adequate market share is now a highly competitive arena. The days of easy millions are long gone, as generic products have become commoditized, with a restriction on high quality standard. 𝘽𝙖𝙘𝙠 𝙞𝙣 𝙙𝙖𝙮𝙨 , 𝙩𝙝𝙚𝙧𝙚 𝙬𝙖𝙨 𝙖 𝙜𝙤𝙤𝙙 𝙜𝙪𝙮𝙨 " 𝙈𝙉𝘾𝙨" 𝙖𝙣𝙙 𝙜𝙚𝙣𝙚𝙧𝙞𝙘 𝙜𝙪𝙮𝙨 " 𝙏𝙖𝙗𝙪𝙠, 𝙅𝙪𝙡𝙥𝙝𝙖𝙧, 𝙅𝙖𝙢𝙟𝙤𝙤𝙢 ,𝙚𝙩𝙘.." 𝙣𝙤𝙬 𝙮𝙤𝙪 𝙘𝙖𝙣 𝙨𝙚𝙚 𝙋𝙛𝙞𝙯𝙚𝙧 𝙘𝙖𝙧𝙧𝙮𝙞𝙣𝙜 𝙜𝙚𝙣𝙚𝙧𝙞𝙘 𝙥𝙤𝙧𝙩𝙛𝙤𝙡𝙞𝙤. The emergence of fierce competition, price reductions mandated by GCC MOHs, and increased market entry costs have reshaped the playing field. Smaller GCC countries, with their limited populations, find it challenging to compete with large-scale Indian producers in the price war. However, there's a silver lining. Government initiatives like national insurance plans and the preference of insurance companies for generics are driving market growth. Additionally, we have seen niche, complex generic segments with attractive margins. To thrive in this dynamic environment, GCC pharma companies must adopt a multifaceted strategy. This includes: 𝙑𝙖𝙡𝙪𝙚-𝙖𝙙𝙙𝙚𝙙 𝙨𝙚𝙧𝙫𝙞𝙘𝙚𝙨: Offering additional services like patient support programs, disease management. 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙞𝙤𝙣: Investing in research and development to develop innovative generic products, such as novel formulations or combination therapies. 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙞𝙘 𝙥𝙖𝙧𝙩𝙣𝙚𝙧𝙨𝙝𝙞𝙥𝙨: Collaborating with other players in the healthcare ecosystem, including CROs, manufacturing partners, and co-promotion , can help reduce costs and expand market reach. 𝘿𝙞𝙜𝙞𝙩𝙖𝙡 𝙩𝙧𝙖𝙣𝙨𝙛𝙤𝙧𝙢𝙖𝙩𝙞𝙤𝙣: Leveraging technology to optimize supply chain management. #biosimilars #specialtygenerics #controlledsubstances #value_addedservices #innovation #partnerships #digitaltransformation #marketdynamics

١٣

١ تعليق واحد

📢 With the healthcare landscape around us in the Middle East region evolving at a rapid pace, the line up of Speakers at the MENHATA Forum 2024 will serve a valuable platform to being updated on Market Access, HEOR, HTA, and RWE trends. Lavni Varyani Pharma BP #MarketAccess #HTA #HEOR #RWE #MENA

٧

١ تعليق واحد

Toward sustainable healthcare, at #THIQAH, we have made a tangible impact in the healthcare sector, enhancing and improving the efficiency of pharmaceutical registration processes according to the highest standards. #Transformational_Stories Learn more: https://ow.ly/wVXU50UbBSM

٤٣

١ تعليق واحد

Don't miss this opportunity to deepen your understanding of the pharmaceutical market in Kuwait and gain a competitive edge. Follow our page for more industry updates: https://lnkd.in/de5zNWmK #KnowYourMarket #KYM #Kuwait #Pharmaceuticals #Pharmamanufacturing #Diabetes #Oncology #CardioVascularDiseases #Obesity #LiverDiseases #Hypertension #Stroke #Oncology #RenalDiseases #COPD #Pharmacompanies #Localmanufacturing #Brandeddrugs #Innovators #LocalManufacturers #Genericdrugs #Generics #Regulatory #Opportunity #MENA #MiddleEast #GCC #Emergingmarkets #NewMarkets #Healthcare #PharmaExports #Data #Insights #RASLifeScienceSolutions #MarketIntelligence #MarketResearch #CompetitiveIntelligence #StrategySupport #PortfolioOptimization #MarketExpansion #PartnerIdentification

٢

𝐎𝐯𝐞𝐫𝐜𝐨𝐦𝐢𝐧𝐠 𝐋𝐚𝐮𝐧𝐜𝐡 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐀𝐄 𝐏𝐡𝐚𝐫𝐦𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 The UAE's pharmaceutical landscape is increasingly competitive, characterized by rising costs, stringent access requirements, and heightened HCPs expectations. I conduct a recent analysis of 36 new drug launches targeting $10 million in sales from 2022 to 2024 underscores the significant hurdles impeding market entry and growth. 𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬: 𝙍𝙚𝙜𝙪𝙡𝙖𝙩𝙤𝙧𝙮 𝘾𝙤𝙢𝙥𝙡𝙚𝙭𝙞𝙩𝙮: A 25% of launches encountered substantial regulatory challenges, resulting in lost revenue. 𝙃𝘾𝙋 𝙀𝙣𝙜𝙖𝙜𝙚𝙢𝙚𝙣𝙩 𝙂𝙖𝙥𝙨: 20% of products failed to establish effective engagement strategies with HCPs 𝙋𝙧𝙞𝙘𝙚 𝙋𝙧𝙚𝙨𝙨𝙪𝙧𝙚𝙨: unfavorable pricing impacted 30% of launches, eroding profitability. 𝙎𝙪𝙥𝙥𝙡𝙮 𝘾𝙝𝙖𝙞𝙣 𝙑𝙪𝙡𝙣𝙚𝙧𝙖𝙗𝙞𝙡𝙞𝙩𝙞𝙚𝙨: 15% experienced supply chain disruptions, hindering their ability to meet market demand. Or fail to meet with MOQ!. 𝙈𝙖𝙧𝙠𝙚𝙩 𝘼𝙘𝙘𝙚𝙨𝙨 𝘽𝙖𝙧𝙧𝙞𝙚𝙧𝙨: 5%t struggled to secure reimbursement from national insurance plans, while another 5% faced challenges gaining entry into key hospitals and pharmacies. 𝙏𝙝𝙚𝙨𝙚 𝙛𝙞𝙣𝙙𝙞𝙣𝙜𝙨 𝙪𝙣𝙙𝙚𝙧𝙨𝙘𝙤𝙧𝙚 𝙩𝙝𝙚 𝙘𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨 𝙥𝙤𝙨𝙚𝙙 𝙗𝙮 𝙩𝙝𝙚 𝙞𝙣𝙩𝙚𝙣𝙨𝙞𝙛𝙞𝙚𝙙 𝙘𝙤𝙢𝙥𝙚𝙩𝙞𝙩𝙞𝙤𝙣 𝙛𝙧𝙤𝙢 𝙀𝙪𝙧𝙤𝙥𝙚𝙖𝙣 𝙖𝙣𝙙 𝘼𝙨𝙞𝙖𝙣 𝙥𝙝𝙖𝙧𝙢𝙖𝙘𝙚𝙪𝙩𝙞𝙘𝙖𝙡 𝙘𝙤𝙢𝙥𝙖𝙣𝙞𝙚𝙨, 𝙬𝙝𝙞𝙘𝙝 𝙝𝙖𝙫𝙚 𝙞𝙣𝙘𝙧𝙚𝙖𝙨𝙞𝙣𝙜𝙡𝙮 𝙡𝙤𝙬𝙚𝙧𝙚𝙙 𝙗𝙖𝙧𝙧𝙞𝙚𝙧𝙨 𝙩𝙤 𝙚𝙣𝙩𝙧𝙮 𝙞𝙣 𝙩𝙝𝙚 𝙐𝘼𝙀 𝙢𝙖𝙧𝙠𝙚𝙩. 𝙏𝙝𝙞𝙨 𝙘𝙤𝙢𝙥𝙚𝙩𝙞𝙩𝙞𝙫𝙚 𝙡𝙖𝙣𝙙𝙨𝙘𝙖𝙥𝙚 𝙣𝙚𝙘𝙚𝙨𝙨𝙞𝙩𝙖𝙩𝙚𝙨 𝙖 𝙘𝙤𝙢𝙥𝙧𝙚𝙝𝙚𝙣𝙨𝙞𝙫𝙚 𝙖𝙣𝙙 𝙥𝙧𝙤𝙖𝙘𝙩𝙞𝙫𝙚 𝙖𝙥𝙥𝙧𝙤𝙖𝙘𝙝 𝙩𝙤 𝙡𝙖𝙪𝙣𝙘𝙝 𝙥𝙡𝙖𝙣𝙣𝙞𝙣𝙜 𝙖𝙣𝙙 𝙚𝙭𝙚𝙘𝙪𝙩𝙞𝙤𝙣

٢١

٤ تعليق

Imagine a world where everyone with MBC gets the most effective treatment. #NoOneMissed, a new campaign from Living Beyond Breast Cancer, raises awareness of the importance of biomarker testing and empowers patients to make informed decisions. Learn more: MBCAlliance.org/NOM24

٥١

١ تعليق واحد